Literature DB >> 6333757

Polypeptides of Mason-Pfizer monkey virus. I. Synthesis and processing of the gag-gene products.

J Bradac, E Hunter.   

Abstract

Mason-Pfizer monkey virus (M-PMV), the prototype D-type retrovirus, differs from the mammalian C-type retroviruses by preassembling core structures in the cytoplasm of infected cells during morphogenesis. Studies that define the protein composition of M-PMV virions and identify two gag-related polyprotein precursors in M-PMV infected cells are reported. The polyprotein precursor to the internal structural (gag) proteins of M-PMV was identified by immunoprecipitation from lysates of pulse-labeled, virus-infected cells with an antiserum to the major structural protein, p27. Tryptic peptide-mapping experiments have shown that this precursor (Pr78) is cleaved to yield five virion structural polypeptides--p27, pp16, p14, p12, and p10. The pp16 polypeptide represents an additional gag-gene encoded polypeptide, not described previously; it is a phosphoprotein and present in virions in a number of forms. A second gag-related polyprotein precursor, P95, is also present in infected cells although in smaller amounts. This nonglycosylated polypeptide contains all of the leucine-containing tryptic peptides of Pr78 plus three others. Studies of the rate of synthesis and half-life of this protein argue against it being the major gag-gene precursor polypeptide. The possibility that it represents a precursor to the viral protease is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6333757     DOI: 10.1016/0042-6822(84)90350-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Activation of the Mason-Pfizer monkey virus protease within immature capsids in vitro.

Authors:  S D Parker; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

Review 2.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  The complete genome and genetic characteristics of SRV-4 isolated from cynomolgus monkeys (Macaca fascicularis).

Authors:  Chih-Ling Zao; Karyn Armstrong; Lisa Tomanek; Anthony Cooke; Ron Berger; J Scot Estep; Preston A Marx; Jessica Satkoski Trask; David G Smith; Joann L Yee; Nicholas W Lerche
Journal:  Virology       Date:  2010-07-07       Impact factor: 3.616

5.  A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.

Authors:  J Yasuda; E Hunter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

6.  Study of the gag-coded polyproteins of type D retroviruses. Block of glycosylation inhibits the processing of major structural protein.

Authors:  P O Ilyinskii; V A Morozov; K V Ilyin
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

7.  Two efficient ribosomal frameshifting events are required for synthesis of mouse mammary tumor virus gag-related polyproteins.

Authors:  T Jacks; K Townsley; H E Varmus; J Majors
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

8.  A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids.

Authors:  S D Parker; E Hunter
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.

Authors:  S S Rhee; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

10.  An early stage of Mason-Pfizer monkey virus budding is regulated by the hydrophobicity of the Gag matrix domain core.

Authors:  Elizabeth Stansell; Ewan Tytler; Mark R Walter; Eric Hunter
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.